|
CA2327685C
(en)
|
1998-04-03 |
2008-11-18 |
Bm Research A/S |
Controlled release composition
|
|
US6572890B2
(en)
*
|
2000-01-13 |
2003-06-03 |
Osmotica Corp. |
Osmotic device containing venlafaxine and an anti-psychotic agent
|
|
US6753011B2
(en)
*
|
2000-01-14 |
2004-06-22 |
Osmotica Corp |
Combined diffusion/osmotic pumping drug delivery system
|
|
US20020044962A1
(en)
*
|
2000-06-06 |
2002-04-18 |
Cherukuri S. Rao |
Encapsulation products for controlled or extended release
|
|
US7674480B2
(en)
*
|
2000-06-23 |
2010-03-09 |
Teva Pharmaceutical Industries Ltd. |
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
|
|
EP1349531A1
(de)
*
|
2001-01-12 |
2003-10-08 |
Sun Pharmaceuticals Industries Ltd. |
System zur beabstandeten abgabe von arzneimitteln
|
|
US6544927B2
(en)
*
|
2001-04-28 |
2003-04-08 |
University Of Florida |
Use of α2-adrenergic receptor agonists and adrenergic inhibitors in reducing defoliation
|
|
CA2443632C
(en)
*
|
2001-04-10 |
2011-05-03 |
Sun Pharmaceutical Industries Limited |
Timed pulse release composition
|
|
IN191028B
(de)
*
|
2001-05-17 |
2003-09-13 |
Sun Pharmaceutical Ind Ltd |
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US20050244498A1
(en)
*
|
2001-09-14 |
2005-11-03 |
Biovail Laboratories, Inc. |
Modified-release compositions of at least one form of venlafaxine
|
|
MXPA04002476A
(es)
|
2001-09-14 |
2004-05-31 |
Anthony A Boiarski |
Dispositivo de nanoporo microfabricado para la liberacion sostenida de agente terapeutico.
|
|
WO2003024430A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Morphine polymer release system
|
|
US20040234602A1
(en)
|
2001-09-21 |
2004-11-25 |
Gina Fischer |
Polymer release system
|
|
US20030073961A1
(en)
*
|
2001-09-28 |
2003-04-17 |
Happ Dorrie M. |
Medical device containing light-protected therapeutic agent and a method for fabricating thereof
|
|
WO2003030920A1
(en)
*
|
2001-10-08 |
2003-04-17 |
Sun Pharmaceutical Industries Limited |
An antispasmodic agent spaced drug delivery system
|
|
TW200302748A
(en)
*
|
2002-02-01 |
2003-08-16 |
Pfizer Prod Inc |
Osmotic delivery system
|
|
EP1509208A1
(de)
*
|
2002-02-04 |
2005-03-02 |
Ranbaxy Laboratories Limited |
Hydrodynamisch ausgleichendes orales arzneimittelabgabesystem mit biphasischer freisetzung
|
|
AR040301A1
(es)
*
|
2002-06-28 |
2005-03-23 |
Alza Corp |
Composicion osmotica expansible y suspension para revestimiento mejoradas
|
|
US20050208132A1
(en)
*
|
2002-07-29 |
2005-09-22 |
Gayatri Sathyan |
Methods and dosage forms for reducing side effects of benzisozazole derivatives
|
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
|
AU2003275953A1
(en)
|
2002-11-08 |
2004-06-07 |
Egalet A/S |
Controlled release carvedilol compositions
|
|
RU2308263C2
(ru)
*
|
2002-12-11 |
2007-10-20 |
Пфайзер Продактс Инк. |
Контролируемое высвобождение активного вещества в среду с высоким содержанием жира
|
|
US20070077301A1
(en)
*
|
2002-12-23 |
2007-04-05 |
Meyer Glenn A |
Venlafaxine osmotic device formulation
|
|
AU2003302147A1
(en)
*
|
2002-12-23 |
2004-07-14 |
Osmotica Costa Rica Sociedad Anonima |
Delivery device containing venlafaxine and memantine and use method thereof
|
|
US8293799B2
(en)
*
|
2003-12-29 |
2012-10-23 |
Osmotica Keresleedelmo és Szolgáltató KFT |
Osmotic device containing a venlafaxine salt and a salt having an ion in common
|
|
WO2004066981A1
(en)
*
|
2003-01-29 |
2004-08-12 |
Sun Pharmaceutical Industries Limited |
Oral controlled release pharmaceutical composition containing metaxalone as active agent
|
|
US20040176465A1
(en)
*
|
2003-03-07 |
2004-09-09 |
Pawan Seth |
Solid compositions containing fluoxetine and a coating
|
|
DE602004031096D1
(de)
|
2003-03-26 |
2011-03-03 |
Egalet As |
Morphin-system mit kontrollierter freisetzung
|
|
WO2004084869A1
(en)
|
2003-03-26 |
2004-10-07 |
Egalet A/S |
Matrix compositions for controlled delivery of drug substances
|
|
WO2004108067A2
(en)
*
|
2003-04-03 |
2004-12-16 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
|
IN2003MU00504A
(de)
*
|
2003-06-05 |
2005-05-13 |
Alembic Ltd |
|
|
JP2007520421A
(ja)
*
|
2003-06-26 |
2007-07-26 |
コリア リサーチ インスティテュート オブ ケミカル テクノロジー |
経口投与用放出制御型薬物送達システム
|
|
KR100601249B1
(ko)
*
|
2003-08-21 |
2006-07-13 |
한국화학연구원 |
경구용 약물 전달 기구용 서방형 다공성 막 형성 조성물
|
|
ES2336913T3
(es)
*
|
2003-08-08 |
2010-04-19 |
Biovail Laboratories International Srl |
Comprimido de liberacion modificada de hidrocloruro de bupropion.
|
|
BRPI0414082A
(pt)
*
|
2003-09-02 |
2006-10-24 |
Pfizer Prod Inc |
formas de dosagem de liberação sustentada de ziprasidona
|
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
|
US7470435B2
(en)
*
|
2003-11-17 |
2008-12-30 |
Andrx Pharmaceuticals, Llc |
Extended release venlafaxine formulation
|
|
WO2005051322A2
(en)
|
2003-11-25 |
2005-06-09 |
Sb Pharmco Puerto Rico Inc. |
Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
|
|
EP1686967A4
(de)
*
|
2003-11-25 |
2012-08-08 |
Smithkline Beecham Cork Ltd |
Carvedilol-freie base, salze, wasserfreie formen oder solvate davon, entsprechende pharmazeutische zusammensetzungen, formulierungen mit kontrollierter freisetzung und behandlungs- oder abgabeverfahren
|
|
US7201920B2
(en)
*
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
US20050129764A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Vergez Juan A. |
Osmotic device containing licofelone
|
|
EP1566173B1
(de)
*
|
2004-02-20 |
2006-08-16 |
Mattern, Udo |
Orale pharmazeutische Zusammensetzung und Verfahren zu ihrer Herstellung
|
|
TW200533391A
(en)
*
|
2004-03-25 |
2005-10-16 |
Sun Pharmaceutical Ind Ltd |
Gastric retention drug delivery system
|
|
PT1765292T
(pt)
|
2004-06-12 |
2017-12-29 |
Collegium Pharmaceutical Inc |
Formulações de fármacos dissuasoras de abuso
|
|
US7713550B2
(en)
*
|
2004-06-15 |
2010-05-11 |
Andrx Corporation |
Controlled release sodium valproate formulation
|
|
US20060177380A1
(en)
*
|
2004-11-24 |
2006-08-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20070231268A1
(en)
*
|
2004-11-24 |
2007-10-04 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20060110327A1
(en)
*
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20080152595A1
(en)
*
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
|
US7241805B2
(en)
|
2005-06-27 |
2007-07-10 |
Biovail Laboratories, Inc. |
Modified release formulations of a bupropion salt
|
|
EP1912622A2
(de)
*
|
2005-08-04 |
2008-04-23 |
Alza Corporation |
Osmotische dosierungsformen mit halbdurchlässigen membranen mit polymer-mischungen mit verbesserten eigenschaften
|
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
|
US20070212703A1
(en)
*
|
2005-09-27 |
2007-09-13 |
Stemmer Willem P |
Proteinaceous pharmaceuticals and uses thereof
|
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
|
US7855279B2
(en)
*
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
RU2457854C2
(ru)
*
|
2005-12-30 |
2012-08-10 |
Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи Лимитед |
Длительное высвобождение нейрегулина для улучшения сердечной функции
|
|
RU2441756C2
(ru)
*
|
2006-03-20 |
2012-02-10 |
Тева Вуменс Хелс, Инк. |
Гибкие прессованные внутривлагалищные кольца, способы их получения и применения и установка для их производства
|
|
US20080081067A1
(en)
*
|
2006-10-03 |
2008-04-03 |
Gupta Manishkumar |
Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
|
|
WO2008148798A2
(en)
|
2007-06-04 |
2008-12-11 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
US20090004281A1
(en)
*
|
2007-06-26 |
2009-01-01 |
Biovail Laboratories International S.R.L. |
Multiparticulate osmotic delivery system
|
|
BRPI0815416A2
(pt)
*
|
2007-08-15 |
2014-10-21 |
Amunix Inc |
Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
|
|
MX2008003230A
(es)
*
|
2008-03-07 |
2009-09-07 |
Senosiain S A De C V Lab |
Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
|
|
WO2010015840A1
(en)
*
|
2008-08-08 |
2010-02-11 |
Cipla Limited |
Osmotic delivery device with modified release
|
|
EP3581579A1
(de)
*
|
2009-02-03 |
2019-12-18 |
Amunix Pharmaceuticals, Inc. |
Verlängerte rekombinante polypeptide und zusammensetzungen damit
|
|
AU2010211220B2
(en)
|
2009-02-06 |
2013-08-01 |
Egalet Ltd. |
Immediate release composition resistant to abuse by intake of alcohol
|
|
AU2010258898B8
(en)
|
2009-06-08 |
2015-02-05 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
|
SG10201704777RA
(en)
|
2009-06-08 |
2017-07-28 |
Amunix Operating Inc |
Growth hormone polypeptides and methods of making and using same
|
|
WO2010149169A2
(en)
|
2009-06-24 |
2010-12-29 |
Egalet A/S |
Controlled release formulations
|
|
JP5813641B2
(ja)
|
2009-08-24 |
2015-11-17 |
アムニクス オペレーティング インコーポレイテッド |
凝固第ｉｘ因子組成物ならびにそれを製造および使用する方法
|
|
AU2010300641B2
(en)
*
|
2009-09-30 |
2016-03-17 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
BR112012022363A2
(pt)
|
2010-03-04 |
2016-07-05 |
Wockhardt Ltd |
forma de dosagem com liberação modificada
|
|
US9173389B2
(en)
|
2010-11-18 |
2015-11-03 |
Auburn University |
Systems and methods to deliver and maintain volatile compounds
|
|
US9185897B2
(en)
|
2010-11-18 |
2015-11-17 |
Auburn University |
Methods to deliver and maintain volatile compounds
|
|
ME02874B
(de)
|
2010-12-22 |
2018-04-20 |
Purdue Pharma Lp |
Gekapselte manipulationssichere Darreichungsformen mit gesteuerter Freisetzung
|
|
CN103327969A
(zh)
|
2010-12-23 |
2013-09-25 |
普渡制药公司 |
抗篡改固体口服剂型
|
|
MY188897A
(en)
|
2012-02-15 |
2022-01-12 |
Bioverativ Therapeutics Inc |
Factor viii compositions and methods of making and using same
|
|
BR112014019901A8
(pt)
|
2012-02-15 |
2018-01-02 |
Biogen Idec Inc |
Proteínas de fator viii recombinante
|
|
MX2014015880A
(es)
|
2012-07-06 |
2015-08-05 |
Egalet Ltd |
Composiciones farmaceuticas disuasivas de abuso para liberacion controlada.
|
|
EP2925304B1
(de)
|
2012-11-30 |
2018-09-05 |
Acura Pharmaceuticals, Inc. |
Selbstregulierende freisetzung eines pharmazeutischen wirkstoffs
|
|
KR101840526B1
(ko)
|
2013-02-05 |
2018-03-20 |
퍼듀 퍼머 엘피 |
내변조성 제약 제제
|
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
EP3033097B1
(de)
|
2013-08-14 |
2021-03-10 |
Bioverativ Therapeutics Inc. |
Faktor viii-xten fusionen sowie ihre verwendungen.
|
|
EP3122337A4
(de)
|
2014-03-26 |
2017-11-08 |
Sun Pharma Advanced Research Company Ltd |
Missbrauchssichere feste darreichungsform mit unmittelbarer freisetzung und beschichtetem reservoir
|
|
TWI741992B
(zh)
|
2015-08-03 |
2021-10-11 |
美商百歐維拉提夫治療公司 |
因子ｉｘ融合蛋白以及其製備及使用方法
|
|
WO2017040607A1
(en)
|
2015-08-31 |
2017-03-09 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for self-regulated release of active pharmaceutical ingredient
|
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
|
WO2018002673A1
(en)
|
2016-07-01 |
2018-01-04 |
N4 Pharma Uk Limited |
Novel formulations of angiotensin ii receptor antagonists
|
|
US10213393B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság |
Composition and method for treating neurological disease
|
|
US20190247331A1
(en)
|
2018-02-15 |
2019-08-15 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
|
US10213394B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
|
KR20210020030A
(ko)
|
2018-05-18 |
2021-02-23 |
바이오버라티브 테라퓨틱스 인크. |
A형 혈우병의 치료 방법
|